IP Library Granted Patent US 11,089,947
Granted Patent B2
US 11,089,947 · App. 16/192,156 · Granted Aug 17, 2021

Catheter with irrigator and/or aspirator and with fiber-optic brain-clot analyzer

Inventor: Assaf Govari (Haifa, IL)
Assignee: BIOSENSE WEBSTER (ISRAEL) LTD.
A61B1/00165A61B1/00087A61B1/00142A61B1/015A61B1/05A61B1/0607A61B8/5238A61B2017/00292A61M1/0031
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,089,947
App. No.
16/192,156
Granted
Aug 17, 2021
Kind
B2
Abstract

A medical system includes a probe, an electrooptical measurement unit, a processor and a treatment unit. The probe, which is configured for insertion into a blood vessel of a brain, includes (a) one or more optical fibers configured to guide an optical signal to interact with a brain clot in the blood vessel, and to output the optical signal that interacted with the brain clot, and (b) a channel selected from a group of channels consisting of an irrigation channel and an aspiration channel. The electrooptical measurement unit is configured to collect and measure the outputted optical signal. The processor is configured to identify a composition of the brain clot by analyzing the measured optical signal from the probe. The treatment unit is configured to provide treatment, selected from the group of treatments consisting of dissolving the brain clot by irrigation and aspiring the brain clot through the channel.

Claims (20)

1. A medical system, comprising:

a catheter having a proximal end and a distal end;

a magnetic position sensor located at the distal end of the catheter to track the distal end of the catheter in a blood vessel of a brain to navigate the distal end of the catheter to a brain clot in the blood vessel;

a one or more optical fibers disposed within the catheter configured to guide an optical signal to interact with the brain clot in the blood vessel, and to output the optical signal that interacted with the brain clot; and

a channel selected from a group of channels consisting of an irrigation channel and an aspiration channel;

an electrooptical measurement unit, configured to collect and measure the outputted optical signal;

a processor, configured to identify a composition of the brain clot by analyzing the measured optical signal from the probe; and

a treatment unit, which is configured to provide treatment, selected from the group of treatments consisting of dissolving the brain clot by irrigation and aspiring the brain clot through the channel.

2. The medical system according to claim 1 , wherein the processor is configured to identify, based on the measured optical signal, whether the brain clot is dissolvable by the group of treatments consisting of dissolving the brain clot by irrigation and aspiring.

3. The medical system according to claim 1 , wherein the processor is configured to output a recommendation for selecting a brain-clot removal method that matches the composition of the brain clot.

4. A method, comprising:

providing a catheter having a proximal end and a distal end;

placing a magnetic position sensor at the distal end of the catheter;

tracking the distal end of the catheter in a blood vessel of a brain to navigate the distal end of the catheter to a brain clot in the blood vessel;

guiding an optical signal via one or more optical fibers in the catheter that is inserted into the blood vessel, to interact with the brain clot in the blood vessel;

collecting from the probe and measuring an outputted optical signal that interacted with the brain clot;

in a processor, identifying a composition of the brain clot by analyzing the measured optical signal from the probe; and

removing the brain clot by at least one treatment, selected from the group of treatments consisting of irrigating the brain clot and applying suction to aspirate the brain clot, using one or more channels in the probe.

5. The method according to claim 4 , wherein identifying the composition of the brain clot comprises identifying whether the brain clot is dissolvable by the group of treatments consisting of dissolving the brain clot by irrigation and aspiring.

6. The method according to claim 4 , and comprising outputting, by the processor, a recommendation for selecting a brain-clot removal method that matches the composition of the brain clot.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 14, 2019
From: GOVARI, ASSAF
To: BIOSENSE WEBSTER (ISRAEL) LTD.
Reel/Frame 048071/0356 →
Continuity (1)
Related Publication 20200154984A1 · May 21, 2020
Cited By (9)
US 12,246,141 US 12,274,834 US 12,409,300 US 12,502,186 US 12,527,587 US 12,575,842 US 12,582,426 US 12,653,558 US 12,667,695